✦ LIBER ✦

Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type

✍ Scribed by Ghislaine Prince; Pia Delaere; Christiane Fages; Thierry Lefrançois; Monique Touret; Marcelle Salanon; Marcienne Tardy

Publisher: Springer
Year: 1995
Tongue: English
Weight: 404 KB
Volume: 20
Category: Article
ISSN: 0364-3190
DOI: 10.1007/bf00969698

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aphasia in senile dementia of the alzhei

Aphasia in senile dementia of the alzheimer type

✍ Kathy Faber-Langendoen; Dr. John C. Morris; John W. Knesevich; Emily LaBarge; J. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Neurochemical parameters in senile demen

Neurochemical parameters in senile dementia of the Alzheimer type

✍ M. Strittmatter; G. Hamann; H. Cramer; C. Reuner; F. Kuntzmann; D. Strubel 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

Senile dementia of the Alzheimer type in

Senile dementia of the Alzheimer type in the lundby study

✍ Olle Hagnell; Annika Franck; Anne Gräsbeck; Rolf Öhman; Leif Öjesjö; Lena Otterb 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 567 KB

Senile dementia of the Alzheimer type in

Senile dementia of the Alzheimer type in the Lundby study

✍ Olle Hagnell; Annika Franck; Anne Gräsbeck; Rolf Öhman; Lena Otterbeck; Birgitta 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

Laminar distribution of neocortical seni

Laminar distribution of neocortical senile plaques in senile dementia of the alzheimer type

✍ C. Duyckaerts; J. -J. Hauw; F. Bastenaire; F. Piette; C. Poulain; V. Rainsard; F 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 862 KB

Milacemide: Safety assessment in senile

Milacemide: Safety assessment in senile dementia of the Alzheimer type

✍ Maurice W. Dysken; T. Daniel Fakouhi; Stacy S. Skare; Joseph Mendels; Peter LeWi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Milacemide, both an MAO-B inhibitor and a prodrug for glycine, has demonstrated cognitive enhancing effects in animal models, in cognitively intact young and elderly, and has been suggested as a potential treatment for senile dementia of the Alzheimer type (SDAT). This multicenter open-label trial e